ArticleFrontiers in oncology2019

The WNT Pathway Is Relevant for the BCR-ABL1-Independent Resistance in Chronic Myeloid Leukemia.

Susanna Grassi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.